Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 2013 Dec. 31,2012 Assets Cash $155,000.00 $150,000.00 Accounts receivable (net) Inventories Investments 7 Land 450,000.00 400,000.00 770,000.00 750,000.00 0.00 100,000.00 500,000.00 0.00 Equipment 1,400,000.00 1,200,000.00 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 " Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 Accrued expenses payable (operating expenses) 45,000.00 50,000.00 14 Dividends payable 30,000.00 25,000.00 15 Common stock, $4 par 700,000.00 600,000.00 14 Paid-in capital in excess of par-common stock 200,000.00 175,000,00 1 Retained eamings 1,360,000.00 950,000.00 Total liabilities and stockholders' equity $2,675,000.00 $2,100,000.00 Additional data obtained from an examination of the accounts in the ledger for 2013 are as follows a. The investments were sold for $175,000 cash b. Equipment and land were acquired for cash c. There were no disposals of equipment during the year. d. The common stock was issued for cash. e. There was a $500,000 credit to Retained Earings for net income f. There was a 500,000 debit to Retained Earnings for cash dividends declared